Overview Fundamentals API Earnings EOD API Sample Code Pricing

ANEBULO PHARMAC. DL-001 (214 F) stock market data APIs

€1.67 -0.05(-2.9%) as of October 29, 2024
Price chart is built with Anychart

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.

ANEBULO PHARMAC. DL-001 Financial Data Overview

1.72
1.67
-
1.73
1.67
1.57-2.88
45 136 K
25 933 K
0
-1.59
-1.016
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '214',
Type: 'Common Stock',
Name: 'ANEBULO PHARMAC. DL-001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'June',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

ANEBULO PHARMAC. DL-001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -0.3
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get ANEBULO PHARMAC. DL-001 Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast -0.03

Get ANEBULO PHARMAC. DL-001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com